logo
Why Six Flags Entertainment (FUN) Is Among the Best Leisure Stocks to Buy Right Now

Why Six Flags Entertainment (FUN) Is Among the Best Leisure Stocks to Buy Right Now

Yahoo10-03-2025
We recently published a list of the . In this article, we are going to take a look at where Six Flags Entertainment Corporation (NYSE:FUN) stands against the other best leisure stocks to buy right now.
According to Allied Market Research, the global leisure travel market had a market size of $1.2 trillion in 2023. It is anticipated to grow at a compound annual growth rate of 18.3% between 2024 and 2033, reaching $6.2 trillion by the end of the forecast period. The rise of social media is one of the key reasons behind the continued growth in leisure travel, as people are gaining increasing awareness and exposure to various industry trends.
The outdoor leisure market is another significant industry in the domain. Outdoor leisure encompasses recreational open-air activities typically conducted in semi-natural or natural environments. According to Business Research Insights, the market was valued at around $13.15 billion in 2024 and is expected to grow at a compound annual growth rate of 6.95% between 2025 and 2033, reaching $24.07 billion by the end of the forecast period.
READ ALSO: and .
A report by Deloitte showed that the leisure industry continued to rebound in fiscal Q3 2024, with total net expenditure increasing from -10.3% in fiscal Q2 2024 to -8.5% in fiscal Q3 2024, reaching the highest level since fiscal Q1 2022. The report showed that nine out of eleven leisure categories reflected increased spending, with short holidays and eating out topping the charts with a 4.7 and 5.5 percentage points increase, respectively.
Although long vacations decreased in popularity due to economic uncertainties and growing expenses, short vacations gained public acknowledgment, as consumers are prioritizing affordability. Casual dining rose by 1.7% year on year, with three new locations opening each week. In addition, live sports, festivals, and concerts drove a 4.1 percentage point increase in net spending on culture and entertainment. Leisure activities at home and pub spending also showed increases, climbing by 1 and 1.7 percentage points, respectively.
However, Deloitte Consumer Tracker anticipates consumer spending to fall in nine out of eleven categories in fiscal Q4 2024. Longer holidays and eating out are expected to have the highest fallout, with a decrease of -8.1 points and -5.9 points, respectively. Cautious consumer spending amid potentially rising inflation and economic uncertainties is anticipated to affect the hospitality industry, necessitating value-driven tactics to attract consumers.
We sifted through stock screeners, online rankings, and ETFs to compile a list of 25 leisure stocks. We then selected the top 12 with the highest number of hedge fund holders as of fiscal Q4 2024. We sourced the hedge fund sentiment data from Insider Monkey's database. The list is sorted in ascending order of hedge fund sentiment.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
People enjoying a sunny day at Knott's Berry Farm amusement park rides.
Number of Hedge Fund Holders: 47
Six Flags Entertainment Corporation (NYSE:FUN) is a regional amusement resort operator with a number of amusement parks, resort properties, and water parks across 17 US states, Mexico, and Canada. Its parks offer a range of leisure experiences, including themed rides, coasters, resorts, and intellectual property such as Looney Tunes, DC Comics, and PEANUTS.
In July 2024, Six Flags completed an $8 billion merger with rival Cedar Fair to produce the largest amusement park operator in the US and form the Six Flags Entertainment Corporation (NYSE:FUN).
In fiscal Q4 2024, the company generated net revenues of $687 million on attendance of 10.7 million visits. These results included $324 million in net revenues and attendance of 5 million visits from legacy Six Flags operations. Six Flags Entertainment Corporation (NYSE:FUN) saw an in-park per capita spending of $61.60, representing an increase of 3% compared to the in-park per capita reported by legacy Cedar Fair in fiscal Q4 2023.
Management said that around 80% of the increase is associated with the impact of operations at the legacy Six Flags parks, with the balance attributable to higher in-park guest spending on food and beverage, extra charge products, and merchandise at the legacy Cedar Fair parks. These trends were reflected in a 3% increase in the average transactions per guest during fiscal Q4 2024.
Overall, FUN ranks 3rd on our list of the best leisure stocks to buy right now. While we acknowledge the potential of FUN as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than FUN but that trades at less than 5 times its earnings, check out our report about the .
READ NEXT: and
Disclosure: None. This article is originally published at .
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Much Would It Take To Earn $100 A Month From Ventas Stock
How Much Would It Take To Earn $100 A Month From Ventas Stock

Yahoo

timean hour ago

  • Yahoo

How Much Would It Take To Earn $100 A Month From Ventas Stock

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Ventas Inc. (NYSE:VTR) is a real estate investment trust that owns and manages a diverse portfolio of healthcare, life science, and senior housing properties across North America and the U.K. It will report its Q2 2025 earnings on July 30. Wall Street analysts expect the company to post EPS of $0.34, down from $0.80 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $1.37 billion, up from $1.20 billion a year earlier. The 52-week range of Ventas stock price was $52.27 to $71.36. Ventas' dividend yield is 3.06%. It paid $1.92 per share in dividends during the last 12 months. Don't Miss: Accredited investors can —with up to 120% bonus shares—before this Uber-style disruption hits the public markets Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — The Latest On Ventas The company on April 30 announced its Q1 2025 earnings, posting FFO of $0.84, compared to the consensus estimate of $0.82, and revenues of $1.36 billion, compared to the consensus of $1.32 billion, as reported by Benzinga. "Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio (SHOP), which powered our first quarter results," said CEO Debra A. Cafaro. The company reaffirmed its full-year 2025 guidance, expecting net income per share in the range of $0.42 to $0.53 and normalized FFO per share of $3.35 to $3.46. Trending: If there was a new fund backed by Jeff Bezos offering a ? How Can You Earn $100 Per Month As A Ventas Investor? If you want to make $100 per month — $1,200 annually — from Ventas dividends, your investment value needs to be approximately $39,216, which is around 620 shares at $63.28 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (3.06% in this case). So, $1,200 / 0.0306 = $39,216 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the stock. The dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). In summary, income-focused investors may find Ventas stock an attractive option for making a steady income of $100 per month by owning 620 shares of stock. Check out this article by Benzinga for three stocks offering high dividend yields. Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." Here's , starting today. Image: Shutterstock This article How Much Would It Take To Earn $100 A Month From Ventas Stock originally appeared on Sign in to access your portfolio

A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money

Yahoo

timean hour ago

  • Yahoo

A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money

Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. However, the company can right the ship through innovation in its core specialty and elsewhere. The stock looks attractively valued at current levels and could beat the market over the next six years. 10 stocks we like better than Novo Nordisk › Investors looking to strike while the iron is hot can buy beaten-down stocks that appear to have excellent chances of bouncing back. And that describes shares of Novo Nordisk (NYSE: NVO) very well. The pharmaceutical leader is down by 52% over the trailing-12-month period as of July 17, but initiating a position now could double investors' money in six years or so. Here's why this stock is a screaming buy at its current levels. Novo Nordisk's recent challenges Novo Nordisk focuses on developing diabetes treatments, an area where it has been a leader for many decades. As of February, it held a 33.3% market share for diabetes drugs. This sort of long-term dominance doesn't happen by accident. The company has consistently attracted top talent in the pharmaceutical industry, which, combined with its extensive experience in diabetes, has enabled it to break new ground repeatedly. Why, then, have the company's shares dropped by 52% over the past year? Because Novo Nordisk failed to impress the market with its financial results and clinical progress. The developments that led to the drugmaker's share plunge would have been excellent for almost any other pharmaceutical company, but investors held it to a higher standard given its rich valuation metrics. For instance, the company reported phase 3 results for CagriSema, an investigational weight management medicine, that proved it's more effective than its famous semaglutide (Wegovy), reducing patients' weight by an average of 22.7% in 68 weeks. However, management was looking for a 25% figure in the study. Very few anti-obesity therapies in development have achieved results comparable to CagriSema, but that was not enough to please investors. The good news: Novo Nordisk's pipeline in diabetes and the fast-growing area of weight management remains robust. The company has several promising candidates in development, including Amycretin, for which it recently initiated late-stage studies. And management has significantly expanded its pipeline through acquisitions. Even with mounting competition, the company should continue to be one of the leaders in its core areas of focus. It's been developing medicines in other fields as well, including various rare diseases (such as the blood disorders beta thalassemia and sickle cell disease), neurological disorders (including Alzheimer's and Parkinson's), and others. Making progress in diabetes and obesity while diversifying its lineup should work wonders for Novo Nordisk down the line. The price is right Net sales in the first quarter grew by 19% year over year to 78.1 billion Danish krone ($12.1 billion). The company's net profit was up 14% year over year to $4.5 billion. These would be excellent results for most similarly sized drugmakers, yet Wall Street remains unimpressed. In my view, that has created a wonderful opportunity to buy shares on the dip. The company's forward price-to-earnings ratio (P/E) has declined significantly over the past year and now stands at 16.9, barely above the healthcare industry's 16.2 and lower than the S&P 500's 22.3. But given Novo Nordisk's still excellent position in its core markets of diabetes and obesity treatments -- the latter of which should grow rapidly in the coming years -- and the company's better-than-average revenue and earnings growth, its stock is arguably worth a steeper premium. In fact, the forward P/E is about as low as it has been in over two years. At current levels, shares look like a steal. Here is how things could evolve for the company in the next six years. First, it could make significant clinical and regulatory progress and launch at least one -- if not several -- blockbuster weight loss or diabetes medications. Second, the company should continue recording strong results, with revenue and earnings moving in the right direction. Lastly, it looks likely to continue increasing its dividend, which it has done significantly over the past half-decade. The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, especially for those who opt to reinvest the dividend. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Prosper Junior Bakiny has positions in Novo Nordisk. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Lucid Soars on Multimillion Uber Deal -- Can It Go Higher Still?
Lucid Soars on Multimillion Uber Deal -- Can It Go Higher Still?

Yahoo

time2 hours ago

  • Yahoo

Lucid Soars on Multimillion Uber Deal -- Can It Go Higher Still?

Key Points Lucid claims to have the world's most advanced electric vehicles. Uber will invest $300 million into Lucid. Lucid will use tech provided by Nuro to outfit its vehicles for driverless Uber operations. 10 stocks we like better than Lucid Group › Famous investor Benjamin Graham said: "In the short run, the market is a voting machine, but in the long run, it is a weighing machine." That quote sure holds true today, after Uber Technologies (NYSE: UBER) shook up the market with its announcement that it will deploy a fleet of robotaxis as demand for autonomous driving vehicles begins to fire on all cylinders. If the market is indeed a short-term voting machine, the market has cast its vote, and Lucid Motors (NASDAQ: LCID) looks like the real winner of this partnership. Lucid's stock popped well over 40% on the news, while Uber traded marginally higher. Let's dig into what this massive development means for the young electric vehicle (EV) maker. Best of the best? When it comes to selecting partners for such a massive deal, Uber could have done a lot worse than selecting the EV company that's brash enough to claim "maker of the world's most advanced electric vehicles." More specifically, on Thursday, Uber announced a partnership that would unleash more than 20,000 robotaxis over the next six years. As previously mentioned, part of the partnership includes Lucid, but another partner is also in the mix: Nuro, an autonomous vehicle start-up. It breaks down like this: Uber will invest $300 million in Lucid, while Nuro develops the self-driving technology that Lucid will deploy in its vehicles to supply Uber with robotaxis. "This investment from Uber further validates Lucid's fully redundant zonal architecture and highly capable platform as ideal for autonomous vehicles, and our industry-leading range and spacious well-appointed interiors, as ideal for ridesharing," said Marc Winterhoff, Interim CEO at Lucid, in a press release. "This is the start of our path to extend our innovation and technology leadership into this multi-trillion-dollar market." This development is a pretty big deal for Lucid. While manufacturing of the 20,000 vehicles in question will be spread over six years and unlikely to start until late next year, it still represents a strong order for the company that just set a quarterly record for deliveries at only 3,309 vehicles, during the second quarter. Moreover, consider that Lucid delivered only 6,418 vehicles during the first half of 2025, and you can understand that 20,000 vehicles for Uber is nothing to sneeze at. In fact, it's about as many vehicles as Lucid hopes to deliver for the full year. Strategic change This partnership marks a new era for Uber, which previously exited the robotaxi space in 2020, and signals that the company's strategy going forward will revolve around partnerships with multiple technology developers. It's also not the only deal Uber is working on. In April, the company announced that Volkswagen will supply its vans for commercial service in Los Angeles next year. While Uber is the driving force behind this multi-million-dollar partnership, it arguably has the roughest road ahead. Driverless vehicle technology has been more challenging and more costly than anticipated, and it's dealing with tight regulations and federal investigations. Those hurdles caused many start-ups to close their doors, including General Motors' Cruise and Ford Motor Company's Argo AI. Uber also has some catching up to do in terms of driverless capabilities. Despite years of delays and missed targets, Tesla did start a pilot program with about a dozen Model Y EVs in Austin, Texas, in June, with plans to expand the service to other U.S. cities later this year. Waymo has also been methodically and quietly growing its operations for years in several U.S. cities with a fleet of roughly 1,500 vehicles. It just crossed 100 million miles of autonomous driving in July. Ultimately, this opens the door to new opportunities for all three companies. But if the market is indeed a voting machine in the short term, there is reason for Lucid investors to be excited. This gets the company's product in front of new customers, in a new addressable market, with partnerships that were once untapped -- it's a big deal, even aside from the $300 million investment. Lucid has a lot of momentum behind it right now, and if the Gravity SUV continues to accelerate its production and deliveries flawlessly, the young EV maker should enter 2026 poised for a tremendous year. While Lucid is likely to give back some of Thursday's large gains, there's little stopping Lucid's stock from climbing higher as deliveries ramp for the Gravity -- especially if the automaker can curb costs and cash burn in the year ahead. Should you buy stock in Lucid Group right now? Before you buy stock in Lucid Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Lucid Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Daniel Miller has positions in Ford Motor Company and General Motors. The Motley Fool has positions in and recommends Tesla and Uber Technologies. The Motley Fool recommends General Motors and Volkswagen Ag. The Motley Fool has a disclosure policy. Lucid Soars on Multimillion Uber Deal -- Can It Go Higher Still? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store